Iradimed (IRMD) Payables (2013 - 2026)

Iradimed (IRMD) has 14 years of Payables data on file, last reported at $2.2 million in Q1 2026.

• On a quarterly basis, Payables fell 15.75% year-over-year to $2.2 million in Q1 2026; TTM through Mar 2026 was $2.2 million, a 15.75% decrease from a year earlier, with the FY2025 full-year figure at $1.8 million, down 4.01% from the prior year.
• Payables for Q1 2026 stood at $2.2 million, up from $1.8 million in the prior quarter.
• Over the last five years, Payables for IRMD reached as high as $9.8 million in Q4 2023 and fell as low as $822118.0 in Q2 2022.
• Historically, Payables has averaged $2.2 million across 5 years, with a median of $1.8 million in 2025.
• Across the five-year window, Payables surged 446.49% in 2023 and sank 80.72% in 2024, its largest moves.
• Year by year, Payables stood at $1.8 million in 2022, then jumped by 446.49% to $9.8 million in 2023, then sank by 80.72% to $1.9 million in 2024, then dropped by 4.01% to $1.8 million in 2025, then rose by 19.89% to $2.2 million in 2026.
• Per Business Quant data, the three most recent Payables figures were $2.2 million in Q1 2026, $1.8 million in Q4 2025, and $2.3 million in Q3 2025.